ASX:LTPPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals
LTR Pharma Ltd
$0.510
Day Range
$0.510 – $0.510
52 Week Range
$0.350 – $0.810
Volume
0.00
Avg Volume (10D)
108.20K
Price Chart
OHLC · volume · moving averages
$0.510+$0.080 (+18.60%)over 6M
Hi$0.645Lo$0.350Avg Vol303.5K
Price-sensitive newsVolumePrev close · 52W rangeDrag the handles below to zoom
Market Statistics
Today's trading range
Open
$0.510
Previous Close
$0.510
Day High
$0.510
Day Low
$0.510
52 Week High
$0.810
52 Week Low
$0.350
Valuation
Fundamental multiples
Market Cap
0.00
Shares Outstanding
0.00
Price to Book
3.31
Trading Activity
Volume & order book
Volume
0.00
Value Traded
0.00
Bid
$0.510 × 1,960
Ask
$0.505 × 4,000
Performance
Returns across timeframes
1 Day
-2.97%
5 Day
0.00%
13 Week
32.43%
52 Week
6.52%
YTD
-31.94%
Technical Indicators
Momentum & moving averages
RSI (14)
54.96
50-Day SMA
$0.501
200-Day SMA
$0.487
— From the desk
Latest News
Biotechnology
LTR Pharma Reports 93% SPONTAN Response in Real-World ED Cohort
LTR Pharma reports 93% real-world ED response to SPONTAN in treatment-experienced men, largest cohort to date, fueling ROXUS US plans.
Biotechnology
LTR Pharma Executes US Commercialisation Agreement with Shed DTC Platform
LTR Pharma inks US ROXUS deal with Shed; targets 150k units in year one via Mavrox telehealth—fast-acting 10-min onset.
Hot Topics
The Weekly Finger: On Green and Gold, and Oil and Gold
Oil inventories near lows despite Iran peace chatter; gold and oil diverge on the energy complex. Small Caps weekly market wrap on ASX stocks.
Biotechnology
LTR Pharma Signs Binding US Telehealth Term Sheet For ROXUS
LTR Pharma signs binding US telehealth term sheet with Shed Holdings for ROXUS via Mavrox; Definitive Agreements in 60 days to kickstart US commercialization.